Supriya Lifescience Legal & Regulatory
Supriya Lifescience disclosed a pending case was admitted by the Supreme Court. An interim order precludes coercive action against directors while the matter is sub judice.
ALFA Filings
Every announcement, straight from the exchange
Every Supriya Lifescience legal & regulatory announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements
Supriya Lifescience disclosed a pending case was admitted by the Supreme Court. An interim order precludes coercive action against directors while the matter is sub judice.
Supriya Lifescience has filed a petition with the Supreme Court of India regarding ongoing judicial proceedings. The matter is currently sub judice and pending consideration.
Bombay High Court ordered provisional release of 200 kg Ketamine Hydrochloride consignment subject to ₹0.72 Crore deposit. Criminal and NDPS proceedings continue.
Supriya Lifescience Limited informed stock exchanges that there have been no new developments regarding ongoing judicial proceedings involving its General Manager.
Supriya Lifescience disclosed legal proceedings against its GM under NDPS Act. Company states no material financial or operational impact is expected.